Trial intelligence / Profile preview

Zhengtian capsules versus flunarizine for migraine

ChiCTR-TRC-13004412Phase 4Completed

Sponsor
Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
Start
Jan 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of Zhengtian capsules in migraine (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoint: Rate of number of migraine attacks cut in half. Started Jan 2013; status: completed.

02

Drugs

Zhengtian capsules
03

Conditions

migraine

Beyond the preview

Go deeper on ChiCTR-TRC-13004412.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-13004412.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call